STRYKER CORP (SYK) Form 10-Q — Jul 31, 2026
Stryker reported net earnings of $1.276 billion for the second quarter of 2026, with net earnings per diluted share of $3.30. The company achieved 9.4% sales growth for the quarter, or 9.0% organic growth excluding acquisitions and divestitures, driven by increased unit volume across all segments. Excluding certain items, adjusted net earnings per diluted share increased 17.9% to $3.69, while adjusted operating income margin rose 170 basis points to 27.4%. The growth was supported by strong performance in both MedSurg and Neurotechnology and Orthopaedics segments, with the latter seeing a 9.1% sales increase in the quarter.
Key figures
- Eps
- 3.30
- Net Income
- 1276
- Cash Position
- 3391
- Adjusted Eps Q2
- 3.69
- Sales Growth Q2
- 9.4%
- Adjusted Net Income Q2
- 1424
- Remaining Buyback Auth
- 1033
- Acquisition Milestone Fv
- 271
- Acquisition Cash Consideration
- 435
Price after filing
Close on the filing date to close N calendar days later (from $352.25). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.